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skeletal muscle protein synthesis at rest ands u m m a r y
Background & aims: Impaired anabolic responses to nutrition and exercise contribute to loss of skeletal
muscle mass with ageing (sarcopenia). Here, we tested responses of muscle protein synthesis (MPS), in
the under represented group of older women, to leucine-enriched essential amino acids (EAA) in
comparison to a large bolus of whey protein (WP).
Methods: Twenty-four older women (65 ± 1 y) received (N ¼ 8/group) 1.5 g leucine-enriched EAA
supplements (LEAA_1.5), 6 g LEAA (LEAA_6) in comparison to 40 g WP. A primed constant I.V infusion of
13C6-phenylalanine was used to determine MPS at baseline and in response to feeding (FED) and feeding-
plus-exercise (FED-EX; 6  8 unilateral leg extensions; 75%1-RM). We quantiﬁed plasma insulin/AA
concentrations, leg femoral blood ﬂow (LBF)/muscle microvascular blood ﬂow (MBF), and anabolic sig-
nalling via immunoblotting.
Results: Plasma insulineamia and EAAemia were greater and more prolonged with WP than LEAA,
although LEAA_6 peaked at similar levels to WP. Neither LEAA or WP modiﬁed LBF or MBF. FED increased
MPS similarly in the LEAA_1.5, LEAA_6 and WP (P < 0.05) groups over 0e2 h, with MPS signiﬁcantly
higher than basal in the LEAA_6 and WP groups only over 0e4 h. However, FED-EX increased MPS
similarly across all the groups from 0 to 4 h (P < 0.05). Only p-p70S6K1 increased with WP at 2 h in FED
(P < 0.05), and at 2/4 h in FED-EX (P < 0.05).
Conclusions: In conclusion, LEAA_1.5, despite only providing 0.6 g of leucine, robustly (perhaps maxi-
mally) stimulated MPS, with negligible trophic advantage of greater doses of LEAA or even to 40 g WP.
Highlighting that composition of EAA, in particular the presence of leucine rather than amount is most
crucial for anabolism.
© 2017 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).A, essential amino acids; WP,
o acids; LBF, leg blood ﬂow;
; SMI, skeletal muscle index;
iﬂuoride; TBST, tris buffered
.
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after exercise in older wome1. Introduction
Healthcare for ageing populations represents a major socio-
economic challenge, e.g. approximately 7% of the EU's GDP is
currently used to provide healthcare for older people. With the
ageing population set to continue to increase in coming years, it is
predicted this ﬁgure will increase to more than 8% by 2060 [1]. Of
paramount clinical concern is age associated muscle loss, termed
sarcopenia, which occurs at a rate of ~1%/y in men and ~0.5%/y in
women beyond the age of 50 y [2]. Such signiﬁcant loss of muscle
mass is an inﬂuential factor in age-related functional impairment,under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
enriched essential amino acid and whey protein bolus dosing upon
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Table 1
Subject demographics for each intervention group. Values are presented as
mean ± SEM.
LEAA_1.5 LEAA_6 WP
Age 65 ± 1 y 63 ± 1 y 66 ± 1 y
Height (m) 1.62 ± 0.02 1.64 ± 0.02 1.60 ± 0.02
Weight (kg) 65.4 ± 3.5 68.4 ± 5.4 65.0 ± 4.6
BMI (kg m2) 25.1 ± 1.3 25.1 ± 1.3 25.0 ± 1.5
SMI 6.32 ± 0.11 6.18 ± 0.13 6.13 ± 0.35
D.J. Wilkinson et al. / Clinical Nutrition xxx (2017) 1e112poor quality-of-life, the onset of metabolic/cardiovascular disease
and an increased mortality risk [3e5].
Both physical activity and nutrition appear to be key regulatory
factors in the control of muscle mass [6]. It is well established that
following the intake of protein/amino acids there is a transient
increase in MPS (peaking at ~2 h; [7,8]), which assists to replenish
protein lost during periods of fasting and hence maintaining stable
musclemass in young adults. This “anabolic window” for increasing
MPS with nutrition is extended when nutrition is combined with
exercise [9e11]. Importantly, responsiveness to anabolic stimuli has
been found to be signiﬁcantly reduced in older adults. For example,
postprandial rises in MPS in older adults are attenuated in com-
parison to young adults [12e15], with reductions as great as 40% in
those consuming the same amount of EAA [13]. Indeed, a recent
study suggests older adults may require a greater quantity (~0.4 g/
kg vs. ~0.24 g/kg in young) of nutrition to exact equivalent anabolic
responses to that of young adults [16,17]. The same anabolic
blunting is also observed in response to acute [18,19] and chronic
resistance exercise training [20,21].
The EAA, in particular leucine, have key roles in regulating the
protein synthetic machinery [22e26]. Indeed 3 g of leucine alone in
the absence of other AA can stimulate MPS to near maximal levels
(equivalent to that observed from a large bolus of whey protein) in
young adult males [24]. With this in mind it has recently been hy-
pothesized that lower doses of EAA enriched with leucine may
provide a robust and less satiating (or caloric) anabolic alternative to
the larger quantities of protein that are suggested to be needed to be
consumed in older age to maximize MPS [27,28]. In support of this
hypothesis we recently showed that despite providing more EAA
substrate, a single bolus of 20 gWP provides no additional anabolic
beneﬁt to that provided by a low dose (3 g), low calorie, and leucine
(40%) enriched EAA supplement (Amino L40, Ajinomoto) [27].
Studies such as this in older women are important since sexual
dimorphism in protein metabolism has been shown in older age
[14,29] and most researchers study only older male populations.
Therefore, as an extension to our previous studies, wequantiﬁed the
effects of 1.5 g or 6 g leucine enriched (LEAA) EAA [40% LEU] nutri-
tion (note: these doses are 50% and 200% of the doses that we pre-
viously tested [27]) in comparison to 40 g WP (a dose elicting an
upper ceiling effect onMPS in youngermales [30]) under rested and
exercised conditions in muscles of older aged women.
2. Materials and methods
2.1. Subject characteristics and ethics
All studies were performed according to the Declaration of
Helsinki and registered at clinicaltrials.gov (registration no.
NCT02053441). Following ethical approval granted by the Univer-
sity of Nottingham Medical School Ethics Committee, twenty-four
older post-menopausal women (8 in each group) matched for age
and BMI (see Table 1 for subject demographics) were recruited from
the local Derbyshire area via advertisement through the mail. To
minimize confounding variables, exclusion criteria included:
impaired mobility, history of diabetes, cardiovascular, pulmonary,
liver or kidney disorders, those on contraindicated medications
(NSAIDS, acetaminophen, HRT) and those currently undergoing
active cancer therapies. Following recruitment and before inclusion
in the project all volunteers were additionally screened by a
physician (at least one week prior to the study day) by means of a
medical questionnaire, physical examination and resting ECG, to
exclude for any metabolic, respiratory, cardiovascular/vascular or
claudication related disorders or other symptoms of ill health. All
volunteers had normal blood chemistry, were normotensive
(BP < 140/90), performed activities of daily living and recreationPlease cite this article in press as: Wilkinson DJ, et al., Effects of leucine
skeletal muscle protein synthesis at rest and after exercise in older womebut were not involved in any formal exercise regimes, and were not
on a weight controlled diet. During screening knee extensor
strength was assessed via 1-RM, using the volunteer's dominant leg
(Technogym, Gambettola, Italy). In addition, lean body mass was
assessed via Dual X-ray Absorptiometry (DXA), and used to mea-
sure appendicular muscle mass and calculate skeletal muscle index
(SMI) according to the following equation [31]:
SkeletalMuscle IndexðSMIÞ¼ðTotalBodySkeletalMuscleMass=
TotalBodyMassÞ100
All subjects provided written, informed consent to participate
after all procedures and risks were explained. Following screening
volunteers were randomly assigned, to one of three groups
receiving either; 1) 40 g Whey Protein (WP, N ¼ 8), 2) 1.5 g Leucine
enriched essential amino acids (LEAA_1.5, N ¼ 8) or 3) 6 g LEAA
(LEAA_6, N ¼ 8). Volunteers were requested not to modify their
normal diet or activity regime before the study day and to refrain
from any form of strenuous physical activity for 48 h prior to the
acute study visit.
2.2. Study procedures
Study procedures followed our standard protocols as previosuly
described by Bukhari et al., [27]. On the morning of the study
(0800 h) following an overnight fast from 2000 h the previous day,
volunteers had a cannula inserted into the antecubital vein of one
arm for the infusion of a L-[ring-13C6]-phenylalanine tracer (Isotec,
Sigma Aldrich; prime: 0.3mg kg1, constant: 0.6mg kg1 h1), with
a retrograde cannula inserted to sample arterialized blood from the
dorsal capillary bed of the hand. Muscle biopsies were taken 1 h
and 3 h after commencement of tracer infusion to permit assess-
ment of basal (post-absorptive) MPS. Volunteers then performed a
bout of unilateral knee extension resistance exercise previously
shown [18] to maximally stimulate MPS (6 8 repetitions at 75% of
their pre-determined 1-RM using the volunteer's dominant leg
with 2 min inter-set rest period). If the volunteer failed to complete
8-repetitions, then an inter-set break was allowed before moving
on to the next set. This happened regularly with sets 5 & 6.
Immediately following the exercise each volunteer consumed their
assigned supplement, either 40 g of whey protein (WP), 1.5 g
(LEAA_1.5) or 6 g (LEAA_6) of LEAA (“Amino L40”; Ajinomoto Inc.,)
prepared in water (250 ml). The AA composition of each supple-
ment is shown in Table 2. This unilateral study design meant that
the non-exercised leg was exposed to the effect of feeding alone
(‘FED’), while the exercised leg was exposed to the combination of
feeding and exercise (‘FED-EX’). Further muscle biopsies were then
taken 2 and 4 h after feeding to permit assessment of MPS over the
intervening periods. Muscle biopsies were collected fromm. vastus
lateralis using the conchotome technique [32] after induction of
local anaesthesia via inﬁltration of 5 ml 1% lignocaine, washed with
ice-cold phosphate buffered saline before being snap frozen in
liquid N2 and stored at 80 C until analysis. Blood samples and
blood ﬂow/vascular measurements were collected as outlined in
the study schematic (Fig. 1).-enriched essential amino acid and whey protein bolus dosing upon
n, Clinical Nutrition (2017), https://doi.org/10.1016/j.clnu.2017.09.008
Table 2
Essential amino acid composition of each type of feed (inclusive of data from Bukhari et al. [27]) Note: L-Lysine monohydrochloride and L-Histidine monohydrochloride
monohydrate were used as L-Lysine and L-Histidine respectively in LEAA.
LEAA (1.5 g), g LEAA (3 g), g LEAA (6 g), g WP (20 g), g WP (40 g), g
L-Leucine 0.6 1.2 2.4 2 4
L-Isoleucine 0.16 0.32 0.64 1.4 2.8
L-Valine 0.165 0.33 0.66 1.2 2.4
L-Threonine 0.14 0.28 0.56 1.4 2.8
L-Lysine 0.25 0.5 1.0 1.8 3.6
L-Methionine 0.05 0.1 0.2 0.4 0.8
L-Histidine 0.025 0.05 0.1 0.4 0.8
L-Phenylalanine 0.1 0.2 0.4 0.6 1.2
L-Tryptophan 0.01 0.02 0.04 0.4 0.8
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Plasma insulin concentration was measured using a high-
sensitivity human insulin enzyme-linked immunosorbent (ELISA)
assay (DRG Instruments GmbH, Marburg, Germany). For AA ana-
lyses, 10 ml of a mix of stable isotopically labelled internal standards
were added to 100 ml of plasma, treated with urease and depro-
teinised with 1 ml ice cold ethanol on ice for 20 min. Following
centrifugation (17,000  g; 10 min), the supernatant was decanted
and evaporated to dryness under nitrogen. Following resuspension
in 0.5 M HCl, lipids were extracted with 2 ml of ethyl acetate before
the lower HCl phase was evaporated and AA were derivatized to
their tBDMS esters. AA concentrations were quantiﬁed against a
standard curve of known concentrations using GCeMS (Trace
1300-ISQ, Thermo Scientiﬁc, Hemel Hempstead, UK).
2.2.2. Measurement of leg blood ﬂow (LBF) and muscle
microvascular blood ﬂow (MBF)
Leg blood ﬂow (LBF) was measured using Doppler ultrasound,
with a 9-3 mHz probe positioned over the origin of the common
femoral artery, and estimated as the product of vessel cross-
sectional area and mean velocity over six cardiac cycles.Fig. 1. Study protocol: effects of leucine-enriched amino acids (LEAA) and whey protein
maximum; CEUS, contrast-enhanced ultrasound.
Please cite this article in press as: Wilkinson DJ, et al., Effects of leucine-
skeletal muscle protein synthesis at rest and after exercise in older womeMicrovascular blood ﬂow was measured using contrast enhanced
ultrasound (CEUS) as previously described [33]. Brieﬂy, Sonovue™
microbubbles (Bracco, Milan, Italy) were infused via an antecubital
vein. An iU22 ultrasound scanner with 40 mm linear 9-3 mHz
probes (Phillips Healthcare, Reigate, United Kingdom) secured on
both anterior thighs was used to register micro-bubble appearance
within the quadriceps muscle at rest and in response to FED and
FED-EX (legs measured individually). Intermittent high mechanical
index (MI) “ﬂashes” disrupted micro-bubbles whilst continuous
low MI recording measured the rate of micro-bubble replenish-
ment. Infusion was at 2 ml min1 for 1 min and 1 ml min1 for 3
subsequent min. During the last 90 s of this measurement protocol,
3  30 s ﬂash/replenishment recordings were made. Off line
region-of-interest analysis using Q-Lab software (Phillips Health-
care, Surrey UK) was used to measure the plateau (“A” value) linear
acoustic intensity and also the rate constant (“b” value); the
product of which is proportional to volume blood volume
tissue1 s1 and thus acts as a measure of muscle tissue micro-
vascular blood ﬂow. In total, 2 studies were done per participant:
ﬁrst 50e60min before the exercise and second 50e60min after the
exercise session (Fig. 1).(WP) at rest and after resistance exercise (RE) in older women. 1-RM, 1-repetition
enriched essential amino acid and whey protein bolus dosing upon
n, Clinical Nutrition (2017), https://doi.org/10.1016/j.clnu.2017.09.008
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Myoﬁbrillar proteins were isolated, hydrolyzed and derivat-
ized using our standard techniques [24]. Brieﬂy, ~25 mg of muscle
biopsy tissue was homogenized in ice-cold homogenization
buffer (50 mM TriseHCl (pH 7.4), 50 mM NaF, 10 mM b-glycer-
ophosphate disodium salt, 1 mM EDTA, 1 mM EGTA, 1 mM acti-
vated Na3VO4 (all SigmaeAldrich, Poole, UK)) and a complete
protease inhibitor cocktail tablet (Roche, West Sussex, UK) at
10 ml mg1 of tissue. Following centrifugation at 13,000  g for
5 min at 4 C, the resulting insoluble pellet was washed three
times with homogenization buffer to remove excess free AA and
solubilized in 0.3 M NaOH to aid separation of the soluble
myoﬁbrillar fraction from the insoluble collagen fraction by sub-
sequent centrifugation. The soluble myoﬁbrillar fraction was
precipitated using 1 M perchloric acid (PCA), pelleted by centri-
fugation and washed twice with 70% ethanol. The protein-bound
AA were released by acid hydrolysis using 0.1 M HCl and 1 ml of
Dowex ion-exchange resin (50W-X8-200) overnight at 110 C. The
free AA were puriﬁed, derivatized and the fractional synthesis
rates (FSR) of the myoﬁbrillar proteins was calculated using the
precursor-product equation below:
FSR ð%=hÞ ¼

DEm
Ep$t

 100
where DEm is the change in enrichment of bound L-[ring-13C6]
phenylalanine in two sequential biopsies, t is the time interval
between two biopsies in hours, and Ep is the mean free L-[ring-13C6]
phenylalanine enrichment in the intramuscular pool.
2.2.4. Immunoblotting for AKT-mTORc1 signalling pathway activity
(i.e. phosphorylation)
Immunoblotting was performed as previously described [26]
using the sarcoplasmic fraction isolated from the MPS prepara-
tion. Sarcoplasmic protein concentrations were analysed using a
NanoDrop ND1000 spectrophotometer (NanoDrop Technologies,
Inc., Wilmington, DE-US) and sample concentrations adjusted to
2 ml mg1 in 3 Laemmli buffer to ensure equivalent protein loading
onto pre-cast 12% Bis-Tris Criterion XT gels (BioRad, Hemel
Hempstead, UK) of 20 mg/lane. Samples were separated electro-
phoretically at 200 V for 1 h, followed by wet transfer of proteins to
PVDF membrane at 100 V for 45 min and subsequently blocking in
2.5% non-fat milk in 1  Tris buffered saline/Tween 20 (TBST) for
1 h. Membranes were incubated in primary antibodies (1:2000
dilution in 2.5% BSA in TBS-T) overnight at 4 C; p70S6K1Thr389,
4EBP1Ser65/70, eEF2Thr56 (New England Biolabs, Hertfordshire, UK).
Membranes were subsequently washed and incubated in HRP-
conjugated secondary antibody (New England Biolabs, Hertford-
shire, UK; 1:2000 in 2.5% BSA in TBST) at ambient temperature for
1 h, before being exposed to Chemiluminescent HRP Substrate
(Millipore Corporation, Billerica, MA-US) for 5 min and bands
quantiﬁed by Chemidoc XRS (BioRad, Hertfordshire, UK). All signals
were within the linear range of detection; loading anomalies were
corrected to coomassie [34].
2.3. Statistical analyses
Data are presented as means ± SEM, except if indicated. Data
were checked for normal distribution using a Kolmogorove
Smirnov Test. Where the assumption of normality was not met,
data were log transformed before further analyses. MPS data were
analysed using a two-way ANOVA (feed type time) with a Tukey's
Post Hoc Test. Plasma and Immunoblotting data were analysed
using two-way repeated measures ANOVA (feed type  time) withPlease cite this article in press as: Wilkinson DJ, et al., Effects of leucine
skeletal muscle protein synthesis at rest and after exercise in older womea Bonferroni correction. All data analysis was performed using
GraphPad Prism (GraphPad Software Inc, San Diego, CA); the alpha
level of signiﬁcance was set at P < 0.05.3. Results
3.1. Plasma AA and insulin concentrations
Plasma EAA (Fig. 2B), BCAA (Fig. 2C) and leucine (Fig. 2D) con-
centrations increased rapidly in both the LEAA-6 and WP groups
peaking at ~40e60 min. In the LEAA_1.5 group there was no sig-
niﬁcant increase in plasma leucine, BCAA or EAA concentrations
above baseline. As expected WP showed greater plasma AA avail-
ability than both the LEAA groups with EAA, BCAA and leucine
concentrations remaining signiﬁcantly elevated above baseline up
to 220 min, whereas concentrations in the LEAA_6 group returned
to baseline within 80 min. Plasma NEAA only increased signiﬁ-
cantly in the WP group (Fig. 2A). Plasma insulin concentration
increased over postabsorptive values in all groups, peaking at
11.5 ± 1.8 uU/mL, 12.8 ± 1.6 uU/mL and 21.0 ± 3.6 uU/mL, for
LEAA_1.5, LEAA_6 and WP respectively (Fig. 2E). However, while
plasma insulin returned to near basal concentration 40 min after
both 1.5 g and 6 g LEAA intake, insulin concentrations in response
to 40 g of WP were signiﬁcantly elevated up to 60 min, with
signiﬁcantly higher insulin concentrations at 20, 40 and
60 min compared to the LEAA. The area under the curve for insulin
was signiﬁcantly greater in response to WP (AUC: 1358 ± 199.4
(WP) vs. 486 ± 92.1 (LEAA_1.5), 494 ± 41.4 (LEAA_6)).3.2. Leg blood ﬂow (LBF) and microvascular blood ﬂow (MBF)
Due to technical issues with the collection of these measure-
ments, MBF and LBF data was only able to be collected for n ¼ 6/
group. No signiﬁcant increases in MBF or LBF were evident in
response to FED, or FED-EX (Fig. 3); nonetheless, it cannot be ruled
out that lack of an effect may have been due to decreased numbers
within each group.3.3. Effects of WP and dose response LEAA on MPS
In the FED leg MPS increased similarly in response to LEAA_1.5
(0.061 ± 0.003 vs. 0.086 ± 0.005%/h, P < 0.05), LEAA_6
(0.066 ± 0.006 vs. 0.090 ± 0.007%/h, P < 0.05) and WP
(0.056 ± 0.004 vs. 0.084 ± 0.011%/h, P < 0.01) over 0e2 h, with MPS
signiﬁcantly greater than basal in the LEAA_6 and WP groups only
over 0e4 h (Fig. 4A). However, in the FED-Ex leg, MPS signiﬁcantly
increased across all the groups from 0 to 4 h (LEAA-1.5,
0.061 ± 0.003 vs. 0.091 ± 0.007%/h, P < 0.01; LEAA-6, 0.066 ± 0.006
vs. 0.097 ± 0.007%/h, P < 0.01 and WP, 0.56 ± 0.004 vs.
0.104 ± 0.011%/h, P < 0.001; Fig. 4B). There were no between group
differences in MPS at any time point.3.4. Effects on muscle anabolic signalling
Anabolic signalling relating to the control of MPS was assessed
by measuring the mechanistic target of rapamycin complex 1
(mTORC1) translational initiation substrates; p70S6K1 and 4E-BP1,
and the elongation factor eEF2. In the FED state, only p-p70S6K1
was signiﬁcantly elevated in the WP group at 2 h and 4 h (Fig. 5A),
however with FED-EX phosphorylation of p70S6K1 was elevated in
both the LEAA_6 and WP groups at 2 h, with phosphorylation
remaining elevated at 4 h in the WP group only (Fig. 5B).-enriched essential amino acid and whey protein bolus dosing upon
n, Clinical Nutrition (2017), https://doi.org/10.1016/j.clnu.2017.09.008
Fig. 2. Time course effects of 1.5 g, 6 g of LEAA or 40 g of WP on plasma amino acids (AA) and insulin concentrations: nonessential AA (NEAA; A), essential AA (EAA; B), branched-
chain AA (BCAA; C), leucine (D), insulin (E), and insulin AUC (F). a: signiﬁcantly different vs. basal (P < 0.05). b: signiﬁcantly different between groups (P < 0.05).
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Fig. 3. The effect of 1.5 g, 6 g of LEAA or 40 g of WP in skeletal muscle of older women on leg blood ﬂow (LBF: A, C & E) and microvascular blood ﬂow (MBF: B, D & F) responses in
the rest and exercise legs.
D.J. Wilkinson et al. / Clinical Nutrition xxx (2017) 1e1164. Discussion
The presence of anabolic resistance in ageing has become
increasingly well documented over recent years, with reports of
increases in MPS being signiﬁcantly dampened in older compared
to younger people in response to anabolic stimuli (i.e exercise;
[18,19], nutrition; [13,35], nutrition & exercise; [36], as well as the
anti-catabolic effects of insulin [37]). Indeed, more recent evidence
has suggested older individuals require greater protein intakes (vs.
young) to achieve similar increases in MPS [16,17,38]. However,
little is known of how nutritional regimens and exercise impactPlease cite this article in press as: Wilkinson DJ, et al., Effects of leucine
skeletal muscle protein synthesis at rest and after exercise in older womeupon skeletal muscle anabolism in older women (who remain
relatively poorly studied vs. men). In the present study we inves-
tigated, in older women, the effects of, and interaction between, the
two major extrinsic drivers of muscle maintenance: nutrition and
exercise. Expanding on our previous ﬁnding that a 3 g dose of LEAA
stimulates MPS to a similar extent to a 20 g WP bolus [27], we
report the novel ﬁndings that there does not appear to exist a bone
ﬁde doseeresponse in MPS to AA feeding (±exercise), in older
women. Older women are an often under-represented population
within nutritional research, this is despite the well-established
sexual dimorphism that exists in terms of muscle protein-enriched essential amino acid and whey protein bolus dosing upon
n, Clinical Nutrition (2017), https://doi.org/10.1016/j.clnu.2017.09.008
Fig. 4. The effects of 1.5 g, 6 g of LEAA or 40 g WP on skeletal muscle myoﬁbrillar protein synthesis in A) FED and B) FED þ EX. a: signiﬁcantly different vs. basal (P < 0.05).
D.J. Wilkinson et al. / Clinical Nutrition xxx (2017) 1e11 7turnover, for example MPS has been shown to be less responsive to
feeding in older women compared to older men [29]. Therefore,
one cannot assume that ﬁndings from males, with regards to
impact on MPS during nutritional or exercise based interventions,
are representative of females, hence the interest in and importance
of the ﬁndings presented herein.
It has been known for ~25 y that EAA are the primary drivers
behind stimulations in MPS through feeding [22,23] ewith leucine
being central to this. Indeed, leucine enriched essential AA (10 g
with 3.5 g Leu) prolongsMPS stimulationwith RE in oldermen [39],
with a high proportion of leucine suggested as being important for
optimal stimulation of MPS by EAA in older adults [40]. Moreover,
we have also previously reported that just 3 g of leucine alone
stimulates MPS to nearmaximal levels (equivalent to that of a largePlease cite this article in press as: Wilkinson DJ, et al., Effects of leucine-
skeletal muscle protein synthesis at rest and after exercise in older womebolus of protein) in youngmen [24] and also that 3 g of a novel LEAA
(1.2 g of leucine) supplement led to a stimulation of MPS in older
women that was equivalent to 20 g of WP [27]. Building on these
previous ﬁndings, we found here that providing as little as 1.5 g of
LEAA (equivalent to 0.6 g leucine and 0.9 g EAA), stimulated fed
state MPS to a similar extent to that of 40 g WP, an amount sug-
gested to maximally stimulate MPS at least in older men [30].
Nonetheless, despite 1.5 g LEAA providing identical stimulation of
MPS at 0e2 h in the rested leg, this dose was unable to sustain
signiﬁcant increases in MPS over the entire 4 h postprandial mea-
surement period, whereas MPS was still raised in both the 6 g LEAA
and 40 gWP at this time. This suggests 6 g LEAA (and 40 gWP)may
be marginally more anabolic than 1.5 g LEAA and 3 g LEAA [27] in
older women (see Fig. 6 for summary), particularly when it comesenriched essential amino acid and whey protein bolus dosing upon
n, Clinical Nutrition (2017), https://doi.org/10.1016/j.clnu.2017.09.008
Fig. 5. The effects of 1.5 g, 6 g of LEAA or 40 g WP on muscle signalling responses to FED and FED-EX. Responses were log transformed and normalized to the basal-fasted biopsy
(represented by dotted line). a: signiﬁcantly different vs. basal (P < 0.05).
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riods. However, based on these ﬁndings (and others; [27]), LEAA
(dosingwith as little as 1.5 g) could therefore act as a supplement to
every meal to ensure robust (perhaps maximal) stimulation of MPS
is achieved in older populations (particularly as LEAA are less
satiating than WP) where the RDA for protein is often not met [41].
It has also been proposed that the delivery proﬁle of the AA
inﬂuences the anabolic response to nutrition, with suggestions that
the rapid aminoacidemia associated with large boluses of fast
absorbing protein (like WP) as being key to maximizing MPS
[42,43]. However, despite there being a rapid ~3 fold peak in plasma
leucine, EAA and BCAA concentrations with 6 g of LEAA, and a
maintenance of higher concentrations for longer with 40 g WP, the
MPS response was similar between groups. This supports previous
ﬁndings whereby bolus feeding of a ﬁxed dose of EAA (15 g), which
led to rapid plasma aminoacidemia, provided no additional
anabolic effects when compared with pulse/spread feeding of the
same total dose, which provided lower later peaking EAA levels [8].
These present data suggest it is the composition of the feed (e.g.
quantity of leucine) rather than the dose or feeding pattern being
the primary driver for anabolism.
Resistance exercise remains a pursuit bywhich to combat loss of
muscle mass with ageing [44], even despite the fact that acute
anabolic responses to exercise are blunted in older age [18,36]. The
addition of exercise to feeding (i.e. FED-EX) leads to an extension of
the anabolic window beyond that of nutrition alone up to 4 h. Since
this occurs in all groups, this indicates only a small dose of leucine
and/or EAA are required in combination with exercise to maintain
elevations in MPS post nutrition, at least over the ﬁrst 4 h. What is
not known from our data is whether these small doses of LEAA are
sufﬁcient to i) extend the anabolic window e.g. vs. 40 g WP, and ii)
stimulate a suppression of MPB to create a net positive balance (as
exercise alone is known to lead to an increase inMPB in the absence
of nutrition [9]). In terms of the latter, based on previous research
showing that as little an increase in circulating insulin from ~5 to
15 uU/ml is sufﬁcient to maximally suppress MPB [45], and the fact
that in the present data even with as little as 1.5 g of LEAA insulin
peaked at ~12 uU/ml (potentially driven through leucine being a1.5 3 6 20 40 
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skeletal muscle protein synthesis at rest and after exercise in older womepotent insulin secretagogue), one may speculate that net balance is
positive in this instance. However, it must be taken into consider-
ation that there is an ageing induced blunting in insulin mediated
suppression of MPB (in older men [37]), therefore the effects of
LEAA on net balance require further investigation.
The study of leg and muscle blood ﬂow though CEUS was per-
formed to assess whether greater doses of EAA or WP may elicit
greater blood ﬂow responses. Despite WP providing ~3 fold greater
AUC for insulin, there were no differences observed in LBF, which is
in line with previous work suggesting the presence of fed-state
vascular resistance in older adults [33,46]. In contrast to our pre-
vious ﬁndings [27] there was no signiﬁcant increases in MBF in any
group in the FED or FED-EX legs; this difference is likely due to the
technical issues with the measurements in the present study (only
MBF in n¼ 6 were able to be collected per group). However, despite
this, we have previously shown that the pharmacological
enhancement of leg and muscle blood ﬂow above the fed response
does not enhance MPS [33], therefore any increase in leg/muscle
blood ﬂow is unlikely to have any additional signiﬁcant inﬂuence
on muscle protein anabolism.
Our present ﬁndings support the ever-growing body of evidence
in the literature for the potent in vivo anabolic role of leucine
[24,27,28,39,47,48], with in vitro data showing that leucine provides
the most robust stimulation of mTORc1 of all EAA [26]. In the
present study the phosphorylation of p70S6K1 was the only
anabolic target increased in the FED or FED-EX state, with 40 g WP
providing the most robust and sustained increase in phosphoryla-
tion, although 6 g LEAA also increased phosphorylation at 2 h in the
FED-EX state. Despite this lack of increase in anabolic signalling,
there was a robust stimulation of MPS for all groups. Discordance
between MPS and anabolic signalling has been previously reported
[7,45] again showing that anabolic signal measurements using
standard immunoblotting approaches are not sensitive quantitative
biomarkers of MPS in response to nutrition and exercise, and in this
instance probably reﬂect between group differences in serum in-
sulin concentrations. This, in addition to the observation of blunt-
ing of anabolic signalling pathways in older age [12,13] may explain
the present ﬁndings. Nonetheless, it is possible that peak signalling1.5 3 6 20 40 
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the key points of stimulation of anabolic signalling in response to
each feed may not have been captured by our biopsy timings e this
is an inherent limitation of such studies.
How can such a low dose of EAA lead to such a robust stimu-
lation of MPS andwhere do the EAA's required to support increased
MPS derive, if not provided in the diet? The increase in MPS in the
absence of exogenous EAA is not an unusual phenomenon over
acute periods of measurement i.e. 90e120 min. Indeed ﬂooding
dose studies, performed more than 20 years ago, showed clearly
that it was possible to stimulate MPS acutely through the provision
of a single bolus of EAA (~3 g Leu or Phe) without the addition of
other EAA [22,23,49]. For this to occur, EAA must be derived from
other pools, i.e. plasma, intracellular or protein (via whole-body or
tissue protein breakdown). We and others have demonstrated, that
acutely, there is clearly sufﬁcient EAA availability to sustain short-
term increases in MPS. In these studies we have shown decreases
in other EAA i.e. intramuscular valine fell by 30% [22], threonine by
20% [23], and indeed upon provision of a low dose whey protein
(6.25 g e equivalent to only 3 g EAA) supplement blood valine,
isoleucine and total EAA concentrations drop (muscle levels were
not measured), yet MPS is still stimulated [50]. Clearly these falls
are the result of increased demand due to elevated MPS. Further-
more, a metabolite of leucine: b-hydroxy-b-methylbutyrate (HMB:
which provides no additional nutritional value), has been shown to
stimulate MPS (whilst also suppressing MPB) acutely in young
males despite providing no additional EAA [24]. This acute stimu-
lated MPS response has also been demonstrated during the provi-
sion of insulin (whereby MPB will also be signiﬁcantly suppressed)
in the absence of additional exogenous EAA [51]. Ergo, it is clear
from the literature that in the short term, the absence of additional
EAA, does not acutely limit MPS. This study was conducted acutely
over 4 h, as part of a larger study investigating the dose response of
MPS to EAA (enriched with leucine) as a potentially less satiating
(and less caloriﬁc) alternative to consuming the larger quantities of
protein suggested to be needed in older age to maximize MPS [52].
Indeed the ﬁndings from the present study support recent evidence
for the positive beneﬁts of similar low dose AA supplementation (in
conjunction with exercise) in supporting anabolism in older adults
[53]. However, the efﬁcacy of LEAA supplementation with meals,
for maintaining muscle mass and function chronically, remains to
be fully tested. Moreover, contradictory ﬁndings for the beneﬁcial
effects of chronic leucine supplementation in ageing have been
reported in the past, with 2.5 g of leucine administered alongside
eachmain meal a day showing no improvements in muscle mass or
strength in healthy older men [54]. However it should be consid-
ered that there are distinct design and methodological differences
between the studies of Verhoeven [54] and Kim [53] which make
comparison difﬁcult. Firstly, the chronic leucine supplementation
in the work of Verhoeven [54] was performed in healthy, non-
sarcopenic males, whereas the work of Kim [53] was performed
speciﬁcally in pre-deﬁned sarcopenic older adults, where supple-
mentation may be most beneﬁcial. Secondly, the leucine supple-
mentation of Verhoeven [54] was provided alongside main meals,
where MPS may already be near maximal and any beneﬁcial effect
could have been negligible. Finally and most importantly, as high-
lighted in our main aims, the work of Verhoeven [54] was per-
formed in a group of older males, here and in the work of Kim [53]
we are speciﬁcally investigating interventions in females, where
known sexual dimorphism particularly in response to nutrition are
well deﬁned [14], thereby potentially explaining why differences
are observed in the outcomes of the two studies.
In summary, our present data expands upon the ﬁndings from
our previous work that a leucine enriched low dose amino acid
supplement provides acute robust (perhaps maximal) stimulationPlease cite this article in press as: Wilkinson DJ, et al., Effects of leucine
skeletal muscle protein synthesis at rest and after exercise in older womeof MPS in older women, with our present data showing as little as
1.5 g of LEAA stimulates MPS to levels equivalent to 40 gWP (a dose
known to maximally stimulate MPS in adult males) both at rest and
after exercise. This supports the potential and longer term evidence
[53] for efﬁcacy of low dose LEAA supplements as strategies to
support muscle massmaintenance in the ageing female population.
Based on these ﬁndings, it would be prudent to investigate the
efﬁcacy in larger cohorts to see if these acute responses to low dose
LEAA are translatable and reproducible over more chronic supple-
mentation periods.
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